descriptive
Analysis v1
Strong Support
In another type of ALS mouse, methylene blue didn’t help them move better or change any of the abnormal brain proteins or inflammation markers that are linked to the disease.
7
0
Evidence from Studies
Supporting (1)
7
Community contributions welcome
7
Methylene blue administration fails to confer neuroprotection in two amyotrophic lateral sclerosis mouse models
Cohort Study
Animal
2012 May 3The scientists gave methylene blue to mice with a form of ALS and found it didn’t help them move better or change the harmful protein buildup in their brains — so the drug didn’t do anything useful in this case.
Contradicting (0)
0
Community contributions welcome
No contradicting evidence found